Profound Medical Corp is seeing a positive shift in its stock price, which indicates growing investor confidence.
Profound Medical Corp (PRN.TO) is up today, with shares increasing by 1.70% to a closing price of CA$8.37. This rise is significant for the company as it navigates a challenging market.
Advertisement
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeMarket cap
$298.84M
52W high
$12.40
52W low
$5.70
1W change
-12.14%
Beta
0.50
Analyst Price Targets
Based on analyst covering PRN · as of Sep 17, 2026
Wall Street analysts forecast PRN stock price to rise 206.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+206.0% Upside
Current Price
C$8.18
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
59.1%
Annualized
90-Day Vol
53.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$6.84
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$7.71 | C$6.29 – C$9.45 |
| 60 trading days | C$7.26 | C$5.44 – C$9.69 |
| 90 trading days | C$6.84 | C$4.81 – C$9.74 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors might view Profound Medical's recent performance as a sign of potential recovery and growth, especially considering its ongoing strategic initiatives.
Profound Medical's Market Cap Approaches CA$300 Million
With a market cap close to CA$300 million, Profound Medical is establishing itself as a notable player in the medical technology sector, despite facing current financial challenges.
Bull case
The stock's rise today could signal renewed interest from investors. This interest may stem from recent management changes and a strategic focus on MRI-guided therapy, which could enhance the company's growth prospects.
Bear case
Even with today's positive movement, investors should be cautious. The company hasn't reported any recent news that could explain the rise, and its profit margin remains negative.
Advertisement
Understanding the Recent Gains
Profound Medical's stock is up today, reflecting a 1.70% increase. This gain may be linked to several factors, including recent management changes that could boost investor confidence. The appointment of Richard Fabian as President and the promotion of Matthew Sobczyk to Interim CFO are seen as steps to strengthen the company's leadership.
Market Sentiment and Future Prospects
While today's gains are encouraging, it's important to stay cautious. The company hasn't announced any significant news that could justify this uptick, and its profit margin is still in the negative. Investors should keep an eye on upcoming financial reports and strategic initiatives that might affect future performance. For more insights, check out the latest updates on Profound Medical's stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
